
InMed Pharmaceuticals Inc (INM)
US$ 3.00990.67%
Price Chart
Key Statistics
Market Cap
$ 4.08M
P/E Ratio
0.00
Revenue (TTM)
$ 4.92M
Volume
14.39K
52W High
$ 9.38
52W Low
$ 1.72
Dividend Yield
0.00%
Beta
0.28
Technicals
50-Day MA
2.8591
200-Day MA
3.7727
52 Week High
9.376
52 Week Low
1.72
About INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.
Employees
13
Headquarters
Vancouver, BC
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.
Latest News
InMed’s INM-901 Shows Promise in Reducing Alzheimer’s Neuroinflammation - TipRanks
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg